Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Theresa Herzog"'
A comprehensive IDA and SWATH-DIA Lipidomics and Metabolomics dataset: SARS-CoV-2 case control study
Autor:
Ammar Tahir, Agnes Draxler, Tamara Stelzer, Amelie Blaschke, Brenda Laky, Marton Széll, Jessica Binar, Viktoria Bartak, Laura Bragagna, Lina Maqboul, Theresa Herzog, Rainer Thell, Karl-Heinz Wagner
Publikováno v:
Scientific Data, Vol 11, Iss 1, Pp 1-12 (2024)
Abstract A significant hurdle in untargeted lipid/metabolomics research lies in the absence of reliable, cross-validated spectral libraries, leading to a considerable portion of LC-MS features being labeled as unknowns. Despite continuous advancement
Externí odkaz:
https://doaj.org/article/3b30a79c33ff4ac695675dee8cbaa6ba
Autor:
Agnes Draxler, Amelie Blaschke, Jessica Binar, Maria Weber, Michael Haslacher, Viktoria Bartak, Laura Bragagna, George Mare, Lina Maqboul, Rebecca Klapp, Theresa Herzog, Marton Széll, Agnese Petrera, Brenda Laky, Karl-Heinz Wagner, Rainer Thell
Publikováno v:
Redox Biology, Vol 67, Iss , Pp 102914- (2023)
COVID-19 infections are accompanied by adverse changes in inflammatory pathways that are also partly influenced by increased oxidative stress and might result in elevated DNA damage. The aim of this case-control study was to examine whether COVID-19
Externí odkaz:
https://doaj.org/article/8ac69bc57fcb4c0d9b848b57dc6d1b4f
Autor:
Rainer Thell, Verena Kallab, Wolfgang Weinhappel, Wolfgang Mueckstein, Lukas Heschl, Martina Heschl, Stefan Korsatko, Franz Toedling, Amelie Blaschke, Theresa Herzog, Anna Klicpera, Clara Koeller, Moritz Haugk, Anna Kreil, Alexander Spiel, Philipp Kreuzer, Robert Krause, Christian Sebesta, Stefan Winkler, Brenda Laky, Marton Szell
Publikováno v:
PLoS ONE, Vol 16, Iss 11, p e0259527 (2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) is currently finally determined in laboratory settings by real-time reverse-transcription polymerase-chain-reaction (rt-PCR). However,
Externí odkaz:
https://doaj.org/article/b83ff6a39a0943e68112a1550e1d4204
Autor:
Verena Kallab, Marton Szell, Amelie Blaschke, Lukas Heschl, Rainer Thell, Anna Klicpera, Alexander O. Spiel, Moritz Haugk, Stefan Winkler, Stefan Korsatko, Wolfgang Mueckstein, Franz Toedling, Philipp Kreuzer, Martina Heschl, Theresa Herzog, Brenda Laky, Christian Sebesta, Anna Kreil, Robert Krause, Wolfgang Weinhappel, Clara Koeller
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 11, p e0259527 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259527 (2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing coronavirus disease 2019 (COVID-19) is currently finally determined in laboratory settings by real-time reverse-transcription polymerase-chain-reaction (rt-PCR). However,
Publikováno v:
The Journal of World Intellectual Property. 5:157-180